Viewing StudyNCT01483144



Ignite Creation Date: 2024-05-06 @ 12:06 AM
Last Modification Date: 2024-10-26 @ 10:44 AM
Study NCT ID: NCT01483144
Status: COMPLETED
Last Update Posted: 2021-06-08
First Post: 2011-11-21

Brief Title: Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis FAP
Sponsor: Cancer Prevention Pharmaceuticals Inc
Organization: Cancer Prevention Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Familial Adenomatous Polyposis
Keywords:
Name View
Sulindac View
Familial Adenomatous Polyposis View
Eflornithine View